Body Fat Accumulation Research Articles

Impact of Hypocaloric Diets on Weight Loss and Body Composition in Obese Dogs: A Meta-Analysis

Canine obesity is a complex, multifactorial condition marked by excessive body fat accumulation due to a sustained positive energy balance. Over the past decade, its global prevalence has risen significantly in most industrialized nations. Despite the availability of numerous commercial diets designed for obesity management in dogs, these products exhibit considerable variability in nutrient composition, and there is currently no standardized guideline on optimal macronutrient levels for effective weight loss. This study aimed to evaluate the effects of specific macronutrient levels on weight loss and body composition in obese dogs. A comprehensive literature search was conducted from 2022 to 2024 across PUBMED, Scielo, Web of Science, and Google Scholar. Out of an initial 1727 documents, 20 studies met the inclusion criteria and were incorporated into this meta-analysis. Diets with energy densities below 3.275 kcal, protein levels above 25%, total dietary fiber exceeding 12%, lower fat (<10%), and reduced non-nitrogenous extract (<40%) demonstrated beneficial effects on all evaluated parameters, including weight loss and body composition assessment. This meta-analysis provides evidence-based nutritional recommendations on optimal caloric, protein, fiber, fat, and carbohydrate levels for hypocaloric diet formulations, supporting healthy weight loss and lean mass preservation in obese dogs. These findings contribute to the development of effective dietary strategies that enhance canine quality of life and longevity.

Comparative analysis of barley dietary fiber fermented with and without Lactiplantibacillus plantarum dy-1 in promoting gut health and regulating hepatic energy metabolism in high-fat diet-induced obese mice.

A previous study has revealed that Lactiplantibacillus plantarum (Lp. plantarum) dy-1 fermentation changed the structural properties and in vitro fecal fermentation characteristics of barley dietary fiber. However, the health-promoting effects of fermented dietary fiber in vivo remained unclear. This study was aimed at comparing the ameliorative effects of barley dietary fiber fermented with or without Lp. plantarum dy-1 on lipid metabolism, gut microbiota composition and hepatic energy metabolism. After a twelve-week intervention, fermented barley dietary fiber (FBDF) reduced the body weight and fat accumulation in liver and epididymal white adipose tissue, improved HFD-induced hyperlipidemia and glucose intolerance, and increased short chain fatty acid (SCFA) levels, exhibiting effects that were better than those of raw barley dietary fiber (RBDF). FBDF supplementation improved the gut microbiota composition, specifically enhancing the abundance of probiotic and SCFA-producing bacteria, such as Akkermansia and Muribaculaceae, while RBDF exhibited regulatory effects on harmful bacteria (Escherichia-Shigella and Desulfovibrionaceae). Additionally, FBDF up-regulated the expression of genes related to energy metabolic processes, such as aerobic respiration and oxidative phosphorylation, inhibited the genes related to lipid biosynthetic metabolism, and improved the activities of hepatic energy metabolism-related enzymes, demonstrating effects that were better than those of RBDF. Therefore, this study indicated the potential of using FBDFs as healthy food resources to prevent obesity or as prebiotics to improve gut microbiota.

Anti-Obesity Effects of a Combination of Whole-Body Vibration Stimulus and Dietary D-Allulose on Rats Fed a High-Fat Diet.

Whole-body vibration (WBV) has gained attention as a light-resistance exercise and can increase energy metabolism. The rare sugar D-allulose has anti-obesity effects that are mediated by the suppression of hepatic lipogenesis. In this study, we examined the anti-obesity effects of a combination of WBV and dietary D-allulose in rats fed a high-fat diet. Thirty-two male Wistar rats (3-wk-old) were randomly assigned to four groups: sedentary control (C), WBV (V), D-allulose (A), and WBV+D-allulose (VA). Rats in Groups A and VA were fed a 5% D-allulose diet, and rats in Groups V and VA were subjected to WBV using a vibrating platform during the 8-wk experimental period. Total abdominal adipose tissue was significantly lower in Groups V, A, and VA than that in Group C, whereas no differences were observed between Groups V, A, and VA. Dietary D-allulose significantly decreased the weights and percentages of carcass and total body fats, whereas the WBV stimulus significant reduced only the total body fat mass. We observed that both long-term WBV stimulation and dietary D-allulose intake inhibited body fat accumulation in rats fed a high-fat diet, which led to obesity; however, no synergistic effect of this combination could be confirmed.

Screening assessment of psycho-emotional state and cardiometabolic risk factors in combatants and civilians during the war in Ukraine

Objective — to conduct the screening assessment of symptoms of psycho‑emotional disorders (post‑traumatic stress disorder (PTSD), general anxiety, perceived stress) and their relationships with metabolic disorders and body composition indicators in combatants and civilians during the war in Ukraine. Materials and methods. 21 combatants with the duration of participation in active hostilities up to 6 months and 20 civilians of the comparison group who permanently resided in Kharkiv and the unoccupied part of Kharkiv region since the beginning of the war were examined. The study included men aged 25 to 55 years without cardiovascular diseases and diabetes. Questionnaires were surveyed using the Post Traumatic Stress Disorder (PTSD) Checklist Scale‑5 (PCL‑5), the Generalized Anxiety Disorder 7 (GAD‑7), and the Perceived Stress Scale 10 (PSS‑10). The body mass index was determined, visceral fat level, percentage of total body fat mass, and muscle mass were measured by bioimpedance. The levels of lipids, blood glucose, glycated hemoglobin were determined, and the triglyceride‑glucose index (TyG) was calculated. Results. Combatants’ PCL‑5 severity scores were only numerically higher than civilians’, and the GAD‑7 severity score was higher (p=0.028). Perceived stress in civilians corresponded to the low level, in combatants — to the moderate level. The PSS‑10 scale scores in combatants was significantly higher than in the comparison group (p=0.018). Among combatants the proportion of individuals with signs of probable PTSD (33.33%) was significantly higher than in civilians (5.00%, p=0.022). Compared to the civilians among the combatants there were also significantly more individuals with moderate and severe general anxiety (28.6% versus 5.0%, respectively, p=0.045). The combatants had higher systolic blood pressure, lower body fat percentage and greater skeletal muscle percentage than the civilians. Metabolic changes in military personnel were characterized by elevated triglyceride levels and lower glycemic indices in comparison to the civilians. In the cоmbatants the assessed severity of PTSD symptoms and perceived stress level were positively correlated with skeletal muscle mass. There were negative correlations between the general anxiety level and fasting glucose, and between the perceived stress level and body fat mass. In the civilians, the severity of symptoms of probable PTSD was positively correlated with body mass index, body fat and visceral fat accumulation, and the triglyceride‑glucose index. The increase in general anxiety and perceived stress levels were associated with the increase in glycemic indices. In addition, the level of general anxiety was inversely correlated with high density lipoprotein cholesterol. Conclusions. In the conditions of ongoing war, the higher proportion of individuals with signs of probable PTSD were found among combatants than among civilians. Compared with civilians, military personnel had higher levels of general anxiety and perceived stress. In civilians, the increase in psycho‑emotional disorders was associated with adverse changes in metabolic parameters and body composition, while in military personnel the accumulation of stressful experiences was correlated with the increase in skeletal muscle mass, the decrease in fat body mass and in glycemia levels.

Semaglutide, liraglutide and tirzepatide: Comparison of effectiveness in the treatment of obesity – a literature review

Introduction Obesity is a complex, multifactorial condition characterized by an excessive accumulation of body fat. It is widely recognized as a major public health issue due to its strong association with numerous chronic diseases. [1][2] The use of GLP-1 receptor agonists in obesity treatment began with the recognition that these drugs, initially developed for type 2 diabetes, could significantly reduce body weight due to their effects on appetite regulation and satiety. Liraglutide was the first to be approved specifically for obesity, followed by semaglutide, The development of tirzepatide, which targets both GLP-1 and GIP receptors, has further expanded the potential for obesity treatment. As clinical evidence continues to support their efficacy and safety, GLP-1 receptor agonists are becoming an important tool in the management of obesity, offering a promising option for individuals struggling with weight and related health conditions [3][4][5]. Aim of the study The aim of this study was to compare the effectiveness of semaglutide, liraglutide and tirzepatide in reducing body weight in obesity. Materials and methods The article was created based on the PubMed and Cochrane databases. The literature was analyzed using the fallow keywords: Obesity treatment, liraglutide, tirzepatide, semaglutide, glucagon-like peptide-1 (GLP-1) receptor agonists Results The research proved that tirzepatide is more effective in reducing body weight compared to semaglutide and liraglutide [6][7]. Conclusion Thanks to the comparison of results from multiple studies, we can assume that, at this point, tirzepatide is the most effective pharmacological treatment for obesity, which, when used in combination with lifestyle changes, provides a lasting effect on weight reduction and, consequently, helps treat obesity-related comorbidities[6][8].

Response of circulating fatty acid binding protein 4 concentration to low-intensity acute aerobic exercise is amplified in an exercise duration-dependent manner in healthy men

BackgroundCirculating fatty acid-binding protein 4 (FABP4) influences cardiovascular disease and glucose metabolism. Acute aerobic exercise increases circulating FABP4 concentrations, but the factors underlying this effect in humans are unclear. We investigated the effect of exercise duration on circulating FABP4 concentrations in healthy men.MethodsThis randomized crossover study enrolled healthy young men randomly assigned to two trials, short-duration (SE) and long-duration (LE) aerobic exercises trials. Both involved acute aerobic exercise followed by 60 min of bed rest. The exercise intensity was the same (40% peak oxygen uptake); however, the duration was 40 and 70 min for the SE and LE trials, respectively. Venous blood samples were collected to measure hormones, metabolites, and FABP4 concentrations.ResultsTwelve healthy young men completed both trials. Changes in hormone levels did not differ significantly between the SE and LE trials (p > 0.05). However, the circulating FABP4 concentration increased significantly only in the LE trial immediately after exercise (p = 0.018). It increased significantly 30–60 min post-exercise in both the SE and LE trials (p < 0.018), with the extent of the increase being significantly higher in the LE trial than in the SE trial (p < 0.001). In each trial, the total incremental area under the curve of circulating FABP4 concentration was significantly positively correlated with body fat percentage (SE trial: rs = 0.699, p = 0.019; LE trial: rs = 0.643, p = 0.024).ConclusionOur findings suggest that exercise duration is associated with the magnitude of increased FABP4 secretion into the blood circulation. Body fat accumulation may also be involved in the magnitude of FABP4 secretion induced by acute aerobic exercise.Trial registrationThe study was pre-registered with the University Hospital Medical Information Network Center (UMIN), a clinical trial registration system (ID: UMIN000051068).

Antibiotic Exposure and Childhood Overweight/Obesity: Evidence From Epidemiological and Experimental Studies.

Childhood overweight and obesity are nutritional disorders in which children's energy intake exceeds energy consumption for a long period, resulting in the excessive accumulation of body fat and weight that exceeds a certain range. It is one of the most serious public health issues. In recent years, its prevalence has shown a significant upward trend, and 41-80% of childhood obesity can persist into adulthood.Scholars are now more interested in researching this further. Since antibiotics have been used extensively since their discovery, more focus has been paid to the possible risks these medications pose to children who are exposed to them. Recently, some studies have explored the possible link between antibiotic exposure and the prevalence of overweight and obesity in children. However, their findings are inconsistent. Therefore, this review aims to synthesize and summarize the studies related to the effects of antibiotics on childhood obesity, elucidate the possible associations between the two, and provide an in-depth discussion of the potential biological mechanisms by which antibiotics exposure may contribute to childhood obesity.

Comparison of Fecal Microbiota and Metabolites Between Captive and Grazing Male Reindeer.

The reindeer (Rangifer tarandus) is a circumpolar member of the Cervidae family, and has adapted to a harsh environment. Summer is a critical period for reindeer, with peak digestibility facilitating body fat accumulation. The gut microbiota plays a pivotal role in nutrient metabolism, and is affected by captivity. However, differences in the composition of the gut microbiota and metabolites between captive and grazing reindeer during summer remain poorly understood. Here, we conducted a comparative study of the fecal microbiota and metabolites between captive (n = 6) and grazing (n = 6) male reindeer, using full-length 16S rRNA gene sequencing and gas chromatography-time-of-flight mass spectrometry, respectively. Our results indicated that Prevotella, Phocaeicola, Papillibacter, Muribaculum, and Bacteroides were the predominant genera in the feces of reindeer. However, microbial diversity was significantly higher in captive reindeer compared to their grazing counterparts. Principal coordinate analysis revealed significant differences in the fecal microbiota between captive and grazing reindeer. In captive reindeer, the relative abundances of the genera Clostridium, Paraprevotella, Alistipes, Paludibacter, Lentimicrobium, Paraclostridium, and Anaerovibrio were significantly higher, while those of the genera Prevotella, Phocaeicola, Pseudoflavonifractor, and Lactonifactor were significantly lower. A comparison of predicted functions indicated that pathways involved in fat digestion and absorption, histidine metabolism, lysine biosynthesis, and secondary bile acid biosynthesis were more abundant in captive reindeer, whereas the pathways of fructose and mannose metabolism and propanoate metabolism were less abundant. An untargeted metabolomic analysis revealed that 624 metabolites (e.g., amino acids, lipids, fatty acids, and bile acids) and 645 metabolites (e.g., carbohydrates and purines) were significantly increased in the feces of captive and grazing reindeer, respectively. In conclusion, we unveiled significant differences in fecal microbiota and metabolites between captive and grazing male reindeer, with the results suggesting a potentially enhanced ability to utilize plant fibers in grazing reindeer.

The effect of oyster mushroom (Pleurotus ostreatus) beta-glucan extract on brain -derived neurotrophic factor and neuron in high-fat-high-fructose diet-induced male Sprague Dawley rats

Obesity is a condition where there is an accumulation of excess body fat, which can increase oxidative stress either in the blood or in tissues, such as brain tissue. This situation can trigger atrophy in neurons and reduce brain-derived neurotrophic factor (BDNF) levels, which can increase the risk of impaired cognitive function. This study aimed to ascertain the effect of oyster mushroom (Pleurotus ostreatus) β-glucan extract on the number of neurons and levels of BDNF in rats. The study design was a true experimental with a randomized control group post-test only with white male Sprague Dawley rats as the subjects. A total of twenty-four rats were divided into four groups, namely the normal diet group fed AIN-93M standard diet (KN), the high-fat-high-fructose (HFHF) diet group (KP), and the HFHF diet group with the addition of β-glucan extract dose of 125 mg/kg body weight (P1), and dose of 375 mg/kg body weight (P2). The BDNF was measured by ELISA, and the number of neurons was by histological staining approach. Although there was no significant difference in the number of neurons (p = 0.692), the data revealed a significant difference in BDNF levels (p = 0.005). There was no relationship between the number of neurons and BDNF levels (p = 0.874) and between the β-glucan dose and the number of neurons (p = 0.796). However, there was a relationship between β-glucan dose and BDNF levels (p = 0.001; r = 0.695). This study concludes that the dose of β-glucan from oyster mushroom extract positively affects BDNF levels but not the number of neurons. There was no relationship between the number of neurons with BDNF levels and β-glucan dose. It was presumable because the staining technique was less specific, so the possibility of other cells counted as neurons may occur

Anti-Obesity Effects of Pleurotus ferulae Water Extract on 3T3-L1 Adipocytes and High-Fat-Diet-Induced Obese Mice.

This study offers promising insights into the anti-obesity potential of Pleurotus ferulae, an edible mushroom valued in Asian cuisine for its nutritional benefits. A hot water extract of P. ferulae (PWE) administered to high-fat diet-induced obese mice over an 8-week period significantly reduced their body weight gain and fat accumulation. PWE not only improved the body weight metrics but also positively influenced the serum lipid profile of obese mice by lowering their total cholesterol and low-density lipoprotein cholesterol levels. In vitro studies using 3T3-L1 adipocytes showed that PWE inhibited adipocyte differentiation and lipid accumulation by downregulating key adipogenic transcription factors, particularly PPARγ and C/EBPα, as well as related lipogenic genes involved in fat synthesis and storage, such as Fabp4, Fasn, and Scd1. Chemical analysis revealed that PWE is rich in polysaccharides, which have been associated with various health benefits, including anti-obesity, anti-diabetic, and anti-cancer properties. These findings suggest that the bioactive compounds in PWE may serve as functional food components that could potentially be applied for the prevention and management of obesity and other metabolic disorders.

Content Analysis through TikTok Social Media Comments: Use of Herbal Medicine

Obesity is a condition where there is excessive accumulation of body fat so that a person's weight is far above normal, this is caused by an imbalance in energy intake and expenditure. The high number of Tiktok users in Indonesia makes Tiktok an effective social media application. This makes the content on Tiktok easily attract the attention of viewers in the field of health and healthy lifestyles in the comments column. This study wants to find out how the audience receives messages from health content creator Dr. Rianti Maharani with the account name @dr.riantiherbal through the comments column. This study uses a qualitative descriptive method with reception analysis theory. The subjects in this study were 17-45 years old, were viewers and provided comments on the @drriantiherbal account. The results of the study found that opposite comments appeared a lot in the comments column, namely 41 comment samples.

A polysaccharide from edible red seaweed Bangia fusco-purpurea prevents obesity in high-fat diet-induced C57BL/6 mice

The study aimed to investigate the impacts of a polysaccharide (BFP) from Bangia fusco-purpurea on high-fat diet (HFD)-induced obesity in C57BL/6 mice, as well as its underlying mechanisms. Our results showed that orally administrated BFP was more effective than inulin (INU) in reducing body weight and fat accumulation in obese mice, indicating its anti-obesity effect. BFP effectively improved the compositions and metabolites of intestinal microbiota in obese mice, leading to enhanced energy metabolism and lipid metabolism, thus contributing to its anti-obesity effect. Notably, the better anti-obesity effect of BFP compared to INU was attributed to their varying degrees of modulation of specific intestinal microbial taxa, such as Clostridium and Aerococcus, as well as the regulation of differential metabolites (including biotin, piperine, G6P, etc.) also varied. Also, both in vitro (3T3-L1 preadipocytes) and in vivo (HFD-induced obese mice) models confirmed that BFP achieved anti-obesity effect attributed to enhance energy metabolism, promote lipolysis, increase fatty acid oxidation, and inhibit adipogenesis via activating the AMP-activated protein kinase and Acetyl-CoA carboxylase signaling pathways and suppressing the peroxisome proliferator-activated receptor γ expression. Our findings suggest that BFP has the potential to be used as prebiotics, dietary agents, and nutritional supplements against obesity.

Euglena Attenuates High-Fat-Diet-Induced Obesity and Especially Glucose Intolerance.

Background: Obesity, a global disease, can lead to different chronic diseases and a series of social health problems. Lifestyle changes, especially dietary changes, are the most effective way to treat obesity. Euglena, a novel food, has attracted much attention. Previous studies have shown that Euglena is an important modulator of the host immune response. In this study, the effects of Euglena as a nutritional intervention in high-fat-diet-induced obese C57BL/6J mice were investigated regarding adipose tissue accumulation and lipid and glucose metabolism by gavage at the dose of 100 mg/kg bodyweight for 9 weeks. This study is one of the few to investigate, in detail, the preventive effects of dietary Euglena on obesity. Methods: Five-week-old male C57BL/6J mice were fed with a high-fat diet (HFD) to induce obesity. An obesity model was created by feeding the high-fat diet for a period of 10 weeks. Obese mice were randomized into 2 groups with the same mean body weight, and no significant differences were observed between the groups: (1) the mice in the HEG group were maintained on a high-fat diet and daily gavaged with Euglena (100 mg/kg body weight) dissolved in saline (n = 7); and (2) the mice in the HFD group were maintained on a high-fat diet and daily gavaged with saline with the same volume (n = 7). The experiment finished after a nine-week period. Results: The results showed that Euglena could reduce the accumulation of white body fat, including subcutaneous fat and visceral fat, and mainly targeted subcutaneous fat. Euglena also reduced adipocyte particle size expansion, promoted lipolysis in adipose (adipose triglyceride lipase and hormone-sensitive triglyceride lipase) and liver tissue (reduced non-esterified fatty acid content), and improved obesity-induced ectopic fat deposition and glucose tolerance. Conclusions: Our findings suggest that Euglena, as a nutritional intervention in HFDs, efficiently reduces body weight and white adipose tissue deposition. The mechanism of Euglena is mainly though enhancing lipolysis. It is worth noting that Euglena β-glucan recovers the hyperglycemia and accumulation of ectopic fat within the liver induced by HFD. Our study is one of the few studies to report in detail the preventive effects of dietary Euglena on obesity in vivo. This study revealed that Euglena also has an important ameliorative effect on obesity and metabolic disorders, which laid a theoretical foundation for its future application in functional foods.

Obesity Prolongs the Pro-Inflammatory Response and Attenuates Bone Healing on Titanium Implants

Obesity is a metabolic disease resulting from excess body fat accumulation associated with chronic systemic inflammation. Obesity has been shown to impact the function and activity of neutrophils, macrophages, and T cells, contributing to higher circulating levels of pro-inflammatory cytokines. Biomaterial surface properties such as roughness and hydrophilicity can influence the behavior of immune cells in the peri-implant microenvironment. This study aimed to determine how obesity induced by a high-fat diet (HFD) affects the inflammatory response to modified titanium (Ti) implants and subsequent bone formation. Obese mice had significantly more neutrophils, pro-inflammatory macrophages, and T cells and fewer anti-inflammatory macrophages and mesenchymal stem cells (MSCs) in the peri-implant tissue than lean mice. Obesity also increased circulating adipokines and pro-inflammatory cytokines when compared to lean animals. Bone formation around Ti implants was reduced in obese mice compared to controls. Adoptive transfer of bone marrow cells isolated from obese mice into wild-type mice demonstrated the localized impact of obesity on immune cell function and phenotype, promoting a pro-inflammatory peri-implant microenvironment and attenuating bone formation post-implantation. These results show that obesity significantly affects the inflammatory response to modified Ti implants, prolonging the pro-inflammatory response to the implanted biomaterial and compromising bone formation. Statement of SignificanceObesity has been shown to significantly alter physiological processes, including the behavior of immune cells, inducing a state of systemic chronic inflammation. Our study demonstrates that obesity-induced via a high-fat diet alters immune cell response to implanted biomaterials, with increased pro-inflammatory response and attenuated immunomodulation resulting in decreased biomaterial integration.

Estimated stearoyl-CoA desaturase activity mediates the associations of total cysteine with adiposity: The Maastricht Study

BackgroundPlasma sulfur amino acids (SAAs), particularly cysteine, are associated with obesity. One proposed mechanism is the altered regulation of the stearoyl-CoA desaturase (SCD) enzyme. Changes in the SCD enzyme activity have been linked to obesity, as well as to plasma SAA concentrations. ObjectiveThis study aimed to investigate whether estimated SCD activity mediates the associations between plasma SAAs and measures of overall adiposity and specific fat depots. MethodsWe examined cross-sectional data from a subset of the Maastricht Study (n=1129, 50.7% men, 56.7% with (pre)diabetes). Concentrations of methionine, total homocysteine, cystathionine, total cysteine (tCys), total glutathione (tGSH) and taurine were measured in fasting plasma. Outcomes included measures of overall, peripheral and central adiposity, and liver fat. SCD activity was estimated by ratios of serum fatty acids as SCD16 and SCD18 indices. The associations between plasma SAAs and measures of adiposity or liver fat were examined with multiple linear regression analysis. Multiple mediation analysis was used to investigate whether the significant associations were mediated by SCD16 and SCD18 indices. ResultsPlasma tCys was positively associated with all adiposity measures (β ranged from 0.15 to 0.30). SCD16 significantly mediated all associations (proportion mediated ranged from 5.1% to 9.7%). Inconsistent mediation effects were found for SCD18. Despite a significant inverse association of plasma tGSH with all adiposity measures (β ranged from -0.08 to -0.16), no significant mediation effect was found. ConclusionsPlasma tCys may promote excessive body fat accumulation via upregulation of SCD activity.

Effects of Intermittent Fasting on Human Metabolism and Evaluation of Its Effectiveness in Weight Loss

Intermittent Fasting (IF), a dietary modification through time-restricted feeding, has gained significant attention in the past few years owing to its advantages in metabolic health and weight management. Available evidence suggests that IF can improve insulin sensitivity; lower the levels of blood glucose and fat; prevent body fat accumulation; and reduce the risk of obesity-related chronic disease by mitigating oxidative damage and affecting the activity of antioxidant enzymes. However, a number of gaps in knowledge remain regarding IF, especially its long-term safety and the generalisability of IF. This paper discussed the effects of IF on metabolism and body health through the mechanism of high-intensity, nutrient-strong IF. It mentioned that IF led to improved insulin sensitivity, lower blood lipid levels and inhibition of body fat accumulation, and was easier to stick to than daily calorie restriction. Other clinical studies with longer intervals and durations also reported significant effects of IF on weight loss and body health. Long term strict IF is unfavorable for some patients – in particular the elderly and the chronically ill – due to the potential for nutritional and metabolic problems. This study serves as an important reference for the use of IF in health and weight loss management, and offers potential directions for future research. Even though IF showed clear benefits, its safety in the long term and applicability across different populations still need to be validated. Future investigations may look into the long-term effects of IF in different populations, and its potential application in various health conditions.

Wheat bran oil ameliorates high-fat diet-induced obesity in rats with alterations in gut microbiota and liver metabolite profile

BackgroundObesity is one of the public health issues that seriously threatens human health. This study aimed to investigate the effects of wheat bran oil (WBO) on body weight and fat/lipid accumulation in high-fat diet (HFD)-induced obese rats and further explore the possible mechanisms by microbiome and metabolome analyses.MethodsFifty Sprague-Dawley (SD) rats were fed either a normal chow diet (B group, n = 10) or HFD (n = 40) for 14 weeks to establish an obesity model. The HFD-induced obese rats were further divided into four groups and given WBO at 0 mL/kg (M group), 1.25 mL/kg (WBO-L group), 2.5 mL/kg (WBO-M group), and 5 mL/kg (WBO-H group) by oral gavage for 9 weeks. The body weight of rats was weighed weekly. The gut microbiota structure was analyzed using 16 S rDNA high-throughput sequencing. The liver metabolite profile was determined using UHPLC-QE-MS non-target metabolomics technology.ResultsIn this study, WBO treatment reduced body weight gain, fat and lipid accumulation, and ameliorated hepatic steatosis and inflammation. WBO treatment increased the relative abundance of Romboutsia and Allobaculum and decreased that of Candidatus_Saccharimonas, Alloprevotella, Rikenellaceae_RC9_gut_group, Alistipes, Parabacteroides, UCG-005, Helicobacter, Colidextribacter, and Parasutterella compared with the M group. A total of 22 liver metabolites were significantly altered by WBO treatment, which were mainly involved in taurine and hypotaurine metabolism, nicotinate and nicotunamide metabolism, phenylalanine, tyrosine and tryptophan biosynthesis, phenylalanine metabolism, and ether lipid metabolism.ConclusionsWBO alleviated body weight gain and fat/lipid accumulation in HFD-induced obese rats, which may be related to altered gut microbiota and liver metabolites.

Mechanisms of Bioactive Lipids to Modulate Master Regulators of Lipid Homeostasis and Inflammation in Metabolic Syndrome.

Metabolic Syndrome (MetS) refers to the co-occurrence of a constellation of metabolic diseases in the same individual, such as abdominal/visceral obesity, insulin resistance or diabetes, alterations in the lipid profile (dyslipidemias), and/or hypertension, which promotes the development of other cardiometabolic and hepatic diseases. Dyslipidemia and metabolic dysfunction- associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease (NAFLD), are common MetS pathologies closely related to lipid metabolism. Alterations in the metabolism of proteins, carbohydrates, and lipids, caused by an excessive intake of nutrients and abnormal accumulation of body fat, which promotes chronic low-grade inflammation, are pivotal aspects of MetS development. To avoid damage caused by lipid overaccumulation, the transcription factors responsible for regulating lipid homeostasis and inflammation (named in this work master regulators) must modify their regular activity; however, the high adiposity established for long periods causes the appearance of insulin resistance (the MetS triggering factor most widely accepted in the literature). Fortunately, scientific evidence suggests that the abnormal activity of these regulators can be conveniently modulated by distinct species of bioactive lipids, among which unsaturated fatty acids stand out, offering new alternatives for treating MetS. Therefore, this work aims to provide a general overview of scientific evidence that supports the mechanisms of action and the effective modulation by bioactive lipids of some master lipid-metabolism-and-inflammation regulators in diverse aspects of MetS.

Novel derivatives of capsaicin as a potent hypolipidemic and anti-obesity agent.

Capsaicin is a natural product with multiple biological activities, such as anti-inflammatory, analgesic, weight loss, anti-cancer and cardiovascular disease prevention. However, its further applications have been limited by its strong irritation, poor water solubility, and unsatisfied pharmacological effects. To ameliorate the problem, a series of derivatives of capsaicin and its analogues were designed and synthesized. Three candidate compounds (HJ-1-3, HJ-1-4, HJ-1-6) have shown the potential to reduce body fat accumulation and lose weight on different indicators with biological evaluation in vitro and in vivo.

Quantitative analysis of fat distribution in men and women: contribution of diet, physical activity, and FTO genotype

BACKGROUND: The Russian Federation is among the top ten countries in terms of obesity prevalence among adults. AIM: To identify the endogenous (biological factors such as age and FTO genotype) and exogenous (diet and physical activity level) factors that influence body fat accumulation and distribution among a group of women and men from Moscow. MATERIAL AND METHODS: A total of 464 volunteers, consisting of 231 women and 233 men aged between 18 and 60 years, from Moscow took part in a single-center, cross-sectional, observational study. The program involved measuring body height, weight, body and limb girths, as well as conducting caliperometry, bioimpedance analysis, and administering questionnaires. Indices of body fat distribution were calculated. Additionally, differences in genotype, specifically the rs9939609 TA variant in the FTO gene, were also determined. RESULTS: Maintaining a vegetarian diet for at least three years was associated with lower fat and fat-free mass, but not with abdominal fat in both men and women. Engaging in regular physical activity had the most significant impact on abdominal fat in both genders. Furthermore, participating in amateur or professional sports activities for a minimum of 180 minutes per week was associated with lower overall body fat. We found no association between the FTO rs9939609 gene and fat accumulation or distribution, regardless of diet and physical activity levels. CONCLUSION: The results suggest that vegetarian diet and regular physical activity are likely to be the most effective total and abdominal fat loss strategy for male and female adult residents of Moscow.